Poly(ADP-ribose) polymerase-1 (PARP1) is a nuclear
enzyme that can trigger
caspase-independent
necrosis. Two main mechanisms for this have been proposed: one involving RIP1 and JNK
kinases and mitochondrial permeability transition (MPT), the other involving
calpain-mediated activation of Bax and mitochondrial release of
apoptosis-inducing factor (AIF). However, whether these two mechanisms represent distinct pathways for PARP1-induced
necrosis, or whether they are simply different components of the same pathway has yet to be tested. Mouse embryonic fibroblasts (MEFs) were treated with either
N-methyl-N'-nitro-N-nitrosoguanidine (
MNNG) or β-
Lapachone, resulting in PARP1-dependent
necrosis. This was associated with increases in
calpain activity, JNK activation and AIF translocation. JNK inhibition significantly reduced
MNNG- and β-
Lapachone-induced JNK activation, AIF translocation, and
necrosis, but not
calpain activation. In contrast, inhibition of
calpain either by Ca(2+) chelation or knockdown attenuated
necrosis, but did not affect JNK activation or AIF translocation. To our surprise, genetic and/or pharmacological inhibition of RIP1, AIF, Bax and the MPT pore failed to abrogate
MNNG- and β-
Lapachone-induced
necrosis. In conclusion, although JNK and
calpain both contribute to PARP1-induced
necrosis, they do so via parallel mechanisms.